Market Exclusive

Analyst Activity – HC Wainwright Reiterates Buy on Concert Pharmaceuticals (NASDAQ:CNCE)

Analyst Ratings For Concert Pharmaceuticals (NASDAQ:CNCE)

Today, HC Wainwright reiterated its Buy rating on Concert Pharmaceuticals (NASDAQ:CNCE) with a price target of $25.00.

Some recent analyst ratings include

Recent Insider Trading Activity For Concert Pharmaceuticals (NASDAQ:CNCE)
Concert Pharmaceuticals (NASDAQ:CNCE) has insider ownership of 10.10% and institutional ownership of 76.61%.

Recent Trading Activity for Concert Pharmaceuticals (NASDAQ:CNCE)
Shares of Concert Pharmaceuticals closed the previous trading session at 21.87 up +0.83 3.94% with shares trading hands.

Exit mobile version